WTA No. 1 Aryna Sabalenka Endorses Genetic Testing Policy

Aryna Sabalenka, the WTA World No. 1, has publicly endorsed the WTA's new genetic testing policy, which took effect July 21, 2026. The WTA became the first professional sports league to mandate such testing for all players.

During a press conference at the 2026 National Bank Open in Toronto, Sabalenka was asked about the tour's new one-time gene testing policy. She emphasized the importance of fairness in women's tennis.

"I think it's really important to keep the fairness in our tour," Sabalenka said. "It's obviously, biologically, the men are way stronger than women, so I feel like it would be not really fair for the woman to compete against biological man."

Her comments come amid broader debates about transgender athletes' participation in women's sports. Indiana Fever star Sophie Cunningham faced backlash after voicing support for barring transgender athletes from girls' and women's sports in a recent ESPN article, which led to protests at Fever games.

Sabalenka, who is preparing for her Women's Singles Round of 64 match at the National Bank Open, made clear that her support is not about targeting individuals but about preserving competitive integrity. "I believe it took them a little while to make this decision and, yeah, I support it. But for me, I'm focusing on myself, on my goals, you know, whatever it takes. If they want to test us all, I'm happy to do that; it's pretty fair, and let's keep it that way."

The policy tests all players for the SRY gene, a DNA sequence typically found on the Y chromosome. It has drawn both praise and criticism. Proponents argue that testing ensures a level playing field, while opponents question the ethics of genetic screening and its implications for privacy and inclusion. The WTA's move could set a precedent for other sports leagues, though no other major organization has yet followed suit.

Sabalenka's stance is notable given her status as the tour's top player. Her willingness to undergo testing and her emphasis on fairness may influence how other athletes and fans perceive the policy. However, she also acknowledged the deliberative process behind the decision, suggesting that even supporters recognize the sensitivity of the issue.

The broader context is a sports world grappling with how to balance inclusion and fairness. The debate extends beyond tennis, touching basketball, track and field, and other sports. As leagues watch the WTA's implementation, the outcome could shape future policies worldwide.

For Sabalenka, the focus remains on her game. But her public endorsement adds a powerful voice to a conversation that is far from settled. Whether the policy achieves its intended goal of fairness—or sparks further controversy—remains to be seen.